Background: Effective interpretation of electrocardiogram (ECG) data is a critical skill for primary health care physicians and part of the Family Medicine residency program curriculum. However, there is a lack of data regarding the competency of Primary Health Care Physicians in ECG interpretation in Saudi Arabia. To evaluate the competence of primary healthcare physicians in Saudi Arabia in interpreting common ECG abnormalities. Additionally, it seeks to understand participants’ perspectives on the facilitators and barriers to effective ECG learning. Methods: A cross-sectional study was conducted from 28 September 2023 to 1 November 2024. A validated questionnaire was used to assess the knowledge of primary health care physicians. Results: A total of 257 physicians participated in the study. Nearly half of the participants (51.8%) attended cardiology rotations and completed the Advanced Cardiac Life Support (ACLS) course. Findings revealed that 74.3% of participants demonstrated poor knowledge of ECG interpretation. Factors significantly contributing to ECG competence included completion of the ACLS course (p-value = 0.035), teaching during clinical rotations as a knowledge source (p-value = 0.020), and participation in ECG courses (p-value = 0.031). Barriers identified encompassed inadequate training programs and inconsistent exposure to ECGs. Conclusion: Primary health care physicians demonstrated unsatisfactory performance in ECG interpretation. Completion of ACLS and dedicated ECG courses, as well as exposure to structured teaching during clinical rotations, were significantly associated with higher competency. Therefore, integrating them into core medical curricula is recommended to enhance ECG interpretation skills among primary health care physicians. Further research is warranted to identify the most effective educational strategies for improving competency in this essential clinical skill.
Background: Epithelial ovarian cancer (EOC) is the leading cause of mortality among gynecologic cancers. The standard treatment approach involves primary debulking surgery (PDS) followed by systemic chemotherapy. Hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as an additional therapeutic option used alongside cytoreductive surgery (CRS); however, its efficacy and safety remain controversial. Objective: This study aims to compare overall survival (OS) and progression-related outcomes between patients receiving standard multimodal treatment with intraoperative HIPEC and those receiving standard multimodal treatment without HIPEC for primary advanced or recurrent EOC, and to evaluate postoperative complications. Methods: A systematic search of Ovid-Medline, Web of Science, and PubMed was conducted without date restrictions through February 2025. Only randomized controlled trials (RCTs) were included. Two reviewers independently performed study quality assessments and data extraction. The protocol was registered in PROSPERO (CRD420251067703). Meta-analysis was conducted using fixed- and random-effects models to pool hazard ratios (HR), risk ratios (RR), and mean differences. Heterogeneity was assessed using the I 2 statistic. Results: Six RCTs ( n = 773) with moderate-quality evidence were included; of these, four studies (555 patients) were conducted in primary settings and two (218 patients) in recurrent settings. The meta-analysis showed a significant improvement in OS among patients with primary ovarian cancer receiving HIPEC (HR = 0.74, 95% CI, 0.60 to 0.92), but no improvement in the recurrent setting (HR = 1.08, 95% CI, 0.62 to 1.90). No significant differences were observed in progression-related outcomes or postoperative complications (primary ovarian cancer: HR = 0.71, 95% CI, 0.43 to 1.18; recurrent ovarian cancer: HR = 1.54, 95% CI, 1.00 to 2.37), (RR = 1.08, 95% CI = 0.94 to 1.24, I 2 = 0.0%), respectively. Conclusion: HIPEC may benefit selected patients with primary advanced EOC, particularly in trials evaluating its use during interval debulking surgery. However, the limited and heterogeneous RCT evidence warrants cautious interpretation. Systematic review registration: CRD420251067703 https://www.crd.york.ac.uk/PROSPERO/view/CRD420251067703